Von Willebrand Disease (VWD) is the most common inherited bleeding disorder worldwide. It affects both males and females from all racial backgrounds with a prevalence rate of 1 in 1000 people. These bleeding events affect the quality of life and survival. Molecular analysis has revealed qualitative and quantitative defects in the etiology of the VWD, thereby creating phenotypic heterogeneity. This phenotypic heterogeneity hampers the prompt diagnosis and appropriate treatment strategy in patients with spontaneous bleeding.
VWD diagnosis is complex and requires a number of tests that are needed to be performed step by step. To enlighten on this, Takeda and Docplexus have organized a webinar on 27 th May 2020, from 6:00 pm to 7:00 pm . In this webinar session, Dr. Suresh Hanagavadi will discuss the topic, titled “Current Challenges In Diagnosis And Management Of Von Willebrand Disease…
